Daiichi Sankyo Articles
Ranbaxy's 2nd-qtr 2008 sales rise 13% to $432M
11 August 2008
Japan stock market week to August 4, 2008
11 August 2008
Teva targets Japanese market, says CEO
4 August 2008
Japan stock market week to July 28, 2008
4 August 2008
Merck KGaA ceases promotion of off-patent drugs
21 July 2008
Japan stock market week to July 14, 2008
21 July 2008
Ranbaxy denies it forged drug data
21 July 2008
Japan stock market week to June 30, 2008
7 July 2008
Three-month delay for US prasugrel NDA
30 June 2008
Japan stock market week to June 23, 2008
30 June 2008
Pfizer to settle patent disputes with Ranbaxy
23 June 2008
Pfizer may counter Daiichi Sankyo bid for Ranbaxy
23 June 2008
Daiichi Sankyo in deal to control Ranbaxy
16 June 2008
Japan stock market week to June 9, 2008
16 June 2008
Mylan sued by Daiichi Sankyo over Azor patent
9 June 2008
JPMA elects new officers
2 June 2008
Japan stock market week to May 26, 2008
2 June 2008
Daiichi Sankyo takes over U3 Pharma
26 May 2008
Japan stock market week to May 19, 2008
26 May 2008
Forest takes $44M hit on ending Azor deal
19 May 2008
Daiichi Sankyo sets up unit in Turkey
19 May 2008
GSK drops Japanese partner for Zantac
28 April 2008
Japan stock market week to April 7, 2008
14 April 2008
Japan stock market week to March 31, 2008
7 April 2008
Daiichi Sankyo extends MorphoSys accord
31 March 2008
Japan stock market week to March 17, 2008
24 March 2008
Daiichi Sankyo to strengthen European presence
17 March 2008
Japan stock market week to Feb 25, 2008
3 March 2008
FDA awards priority review for prasugrel
3 March 2008
FDA accepts NDA for Kissei's BPH drug
25 February 2008
Tokyo stocks in the week to February 18, 2008
25 February 2008
Japanese pharma companies are steadily penetrating global markets
25 February 2008
Japan stock market week to February 4 , 2008
14 February 2008
US physician survey finds big differences in Rx patterns between cardiologists and PCPs
4 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
Japan stock market week to Jan 21, 2008
28 January 2008
Daiichi Sankyo and Eli Lilly submit NDA to US FDA for prasugrel; to be sold as Effient
14 January 2008
FDA clears orphan drug Kuvan for PKU
14 January 2008
Christian Deleuze and Michael Seeley join LEEM
14 January 2008
Tokyo stocks to January 7, 2008
14 January 2008
Olmetec first ARB to show sclerotic regress
17 December 2007
Japan stock market week to Dec 10, 2007
17 December 2007
Daiichi Sankyo to ramp up US operations
3 December 2007
Japan stock market week to Nov 26, 2007
3 December 2007
Lilly/Daiichi Sankyo's prasugrel cuts CV AEs 19% vs Plavix, but side effects raise doubts
21 November 2007
Japan stock market week to Nov 12, 2007
19 November 2007
Japan stock market week to November 5, 2007
12 November 2007
Japan stock market week to Oct 29, 2007
5 November 2007
Two prasugrel trials suspended on dosage issues
29 October 2007
Forest's EPS drops 5% on Microbia charge
29 October 2007
Daiichi Sankyo and Forest finalize Azor co-promotion deal
22 October 2007
Statins provide benefits after use stopped
22 October 2007
Tokyo stocks to October 8, 2007
15 October 2007
Daiichi Sankyo files CS-8663 in Europe
8 October 2007
YM Biosci's fiscal 2007 income triples to $7.6M
8 October 2007
Japan stock market week to September 24, 2007
1 October 2007
BioMarin grants exclusive data on Kuvan to Asubio
24 September 2007
Small number of combination drugs reaching the Japanese market
24 September 2007
Daiichi Sankyo strengthens UK marketing team
17 September 2007
US adults with high cholesterol fail to take necessary step to improve their condition
17 September 2007
Japan stock market week to September 3, 2007
10 September 2007
Daiichi Sankyo and Forest sign US promotion deal
3 September 2007
Japan stock market week to August 6, 2007
13 August 2007
Japan stock market week to July 30, 2007
6 August 2007
Amgen/Daiichi Sankyo sign denosumab deal
23 July 2007
Japan stock market week to July 16, 2007
23 July 2007
Forest's income for fiscal 1st qtr soars 34%
23 July 2007
Japan stock market week to July 2, 2007
9 July 2007
Japan stock market week to June 11, 2007
18 June 2007
Japan stock market week to June 4, 2007
11 June 2007
UK's ABPI welcomes new members
4 June 2007
Japan stock market week to May 28, 2007
4 June 2007
Combined bp drug Azor discussed at ASH
28 May 2007
Japan stock market week to May 21, 2007
28 May 2007
Japan stock market week to May 7, 2007
14 May 2007
Japan stock market week to April 30, 2007
7 May 2007
Japan's five-year plan for drug innovation
7 May 2007
Japan stock market week to April 23, 2007
30 April 2007
Japan stock market week to April 16, 2007
23 April 2007
Japan
9 April 2007
Daiichi Sankyo completes post-merger integration
9 April 2007
Japan stock market week to March 12, 2007
19 March 2007
Japan stock market week to Feb 12, 2007
19 February 2007
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
